MUZI, ALESSIA
 Distribuzione geografica
Continente #
NA - Nord America 8.722
EU - Europa 1.893
AS - Asia 815
SA - Sud America 95
AF - Africa 10
OC - Oceania 4
Totale 11.539
Nazione #
US - Stati Uniti d'America 8.703
IT - Italia 1.000
SG - Singapore 358
CN - Cina 206
DE - Germania 182
FR - Francia 133
UA - Ucraina 121
RU - Federazione Russa 110
BR - Brasile 77
VN - Vietnam 76
IE - Irlanda 62
HK - Hong Kong 60
NL - Olanda 59
SE - Svezia 53
FI - Finlandia 42
GB - Regno Unito 41
PL - Polonia 40
JP - Giappone 25
KR - Corea 25
CZ - Repubblica Ceca 21
IN - India 12
BD - Bangladesh 11
CA - Canada 9
MX - Messico 9
AR - Argentina 7
ES - Italia 6
ID - Indonesia 6
TR - Turchia 6
UZ - Uzbekistan 5
AU - Australia 4
CH - Svizzera 4
PH - Filippine 4
AT - Austria 3
CO - Colombia 3
KE - Kenya 3
LT - Lituania 3
MY - Malesia 3
PK - Pakistan 3
ZA - Sudafrica 3
AL - Albania 2
BG - Bulgaria 2
HR - Croazia 2
IL - Israele 2
IQ - Iraq 2
KZ - Kazakistan 2
MA - Marocco 2
TW - Taiwan 2
UY - Uruguay 2
VE - Venezuela 2
BE - Belgio 1
BH - Bahrain 1
BY - Bielorussia 1
CL - Cile 1
EC - Ecuador 1
EE - Estonia 1
GD - Grenada 1
GE - Georgia 1
GY - Guiana 1
IR - Iran 1
KG - Kirghizistan 1
LB - Libano 1
MK - Macedonia 1
NG - Nigeria 1
NO - Norvegia 1
OM - Oman 1
PT - Portogallo 1
RO - Romania 1
SR - Suriname 1
SY - Repubblica araba siriana 1
ZW - Zimbabwe 1
Totale 11.539
Città #
Woodbridge 2.643
Houston 2.106
Wilmington 1.937
Ann Arbor 244
Singapore 228
Chandler 226
Fairfield 219
Ashburn 156
Rome 105
Jacksonville 104
Seattle 83
San Jose 79
New York 75
Beijing 74
Milan 71
Cambridge 65
Dublin 61
Hong Kong 58
Medford 51
Dallas 42
Santa Clara 31
The Dalles 31
Kraków 30
Los Angeles 29
Dearborn 28
Council Bluffs 27
Ho Chi Minh City 24
Lawrence 24
Prague 21
Naples 19
Tokyo 19
Helsinki 18
Mülheim 18
Buffalo 14
Catania 14
Zhengzhou 14
Florence 13
Hanoi 13
Palo Alto 13
Turin 13
Falls Church 12
Guangzhou 12
Shanghai 12
Boardman 11
Menlo Park 11
Moscow 10
Pisa 9
San Diego 9
Verona 9
Bologna 8
Civitavecchia 8
Columbus 8
Hefei 8
São Paulo 8
Bari 7
London 7
Pioppi 7
University Park 7
Brescia 6
Mountain View 6
Napoli 6
Pavia 6
Da Nang 5
Lauterbourg 5
Orem 5
Phoenix 5
Reggio Emilia 5
San Mateo 5
Toronto 5
Calusco d'Adda 4
Jakarta 4
Nanjing 4
Novara 4
Nuremberg 4
Padova 4
Palermo 4
Redwood City 4
Saint Petersburg 4
Tashkent 4
Treviso 4
Altopascio 3
Atlanta 3
Brasília 3
Cagliari 3
Chennai 3
Chicago 3
Curitiba 3
Dong Ket 3
Ercolano 3
Ferrara 3
Fidenza 3
Haiphong 3
Jinan 3
Kunming 3
Lecce 3
Manchester 3
Massa 3
Montreal 3
Pordenone 3
Pune 3
Totale 9.366
Nome #
Gli inibitori della poli (ADP-ribosio) polimerasi (PARP) per superare la chemioresistenza a metilanti e inibitori di topoisomerasi I 1.530
Common fragile sites in colon cancer cell lines: role of mismatch repair, RAD51 and poly(ADP-ribose) polymerase-1 529
Valproic acid activity in androgen-sensitive and -insensitive human prostate cancer cells 489
Stable depletion of poly (ADP-ribose) polymerase-1 reduces in vivo melanoma growth and increases chemosensitivity 478
Poly(ADP-ribose) glycohydrolase inhibitor as chemosensitiser of malignant melanoma for temozolomide 477
A novel water-soluble nitrobenzoxadiazole is highly effective against vemurafenib-resistant human melanoma cells 472
Poly(ADP-ribose) polymerase signaling of topoisomerase 1-dependent DNA damage in carcinoma cells 458
The integrin antagonist cilengitide increases the antitumor activity of temozolomide against malignant melanoma 458
Oral administration of PARP inhibitor GPI 18180 increases the anti-tumor activity of temozolomide against intracranial melanoma in mice. 453
Novel Glutathione S-Transferase Inhibitor Enhances Temozolomide Efficacy Against Malignant Melanoma 52nd Annual Meeting of the Italian Cancer Society. Lost in translation: bridging the gap between cancer research and effective therapies 451
The glutathione transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) increases temozolomide efficacy against malignant melanoma 442
Role of PARP, NF-kB and telomerase in necrosis induced by selective methylation of N3-adenine. 437
Pharmacological inhibition of poly(ADP-ribose) polymerase-1 modulates resistance of human glioblastoma stem cells to temozolomide. 431
Pharmacological Inhibition of Poly(ADP-ribose) Polymerase (PARP) Activity in PARP-1 Silenced Tumour Cells Increases Chemosensitivity to Temozolomide and to a N3-Adenine Selective Methylating Agent. 424
Poly(ADP-ribose) polymerase (PARP) inhibition or PARP-1 gene deletion reduces angiogenesis 420
Pharmacological inhibition of poly(ADP-ribose) polymerase activity down-regulates the expression of syndecan-4 and Id-1 in endothelial cells 418
Pharmacological inhibition of poly (ADP-ribose) polymerase (PARP) activity down-regulates the expression of syndecan-4 and Id-1 in endothelial cells and increases temozolomide sensitivity of PARP-1 silenced melanoma cells. 414
Evidence that corticotropin-releasing hormone inhibits cell growth of human breast cancer cells via the activation of CRH-R1 receptor subtype. 413
Evidence of the crucial role of the linker domain on the catalytic activity of human topoisomerase I by experimental and simulative characterization of the Lys681Ala mutant 404
Placenta growth factor induces melanoma resistance to temozolomide through a mechanism that involves the activation of the transcription factor NF-κB 403
Generation of an immortalized human endothelial cell line as a model of neovascular proliferating endothelial cells to assess chemosensitivity to anticancer drugs. 401
Targeting angiogenesis with poly(ADP-ribose) polymerase inhibitors 392
Inhibition of poly(ADP-ribose) polymerase prevents irinotecan-induced intestinal damage and enhances irinotecan/temozolomide efficacy against colon carcinoma. 373
Stable depletion of poly (ADP-ribose) polymerase-1 reduces in vivo melanoma growth and increases chemosensitivity to temozolomide. 17th International Symposium on poly(ADP-ribosyl)ation. 363
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models 55
Totale 11.585
Categoria #
all - tutte 23.107
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.107


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202187 0 0 0 0 0 0 0 0 0 0 55 32
2021/2022296 9 29 25 13 5 32 6 8 45 36 6 82
2022/2023582 50 50 27 78 38 92 26 41 72 26 43 39
2023/2024449 43 22 38 44 30 87 36 25 18 22 32 52
2024/2025772 44 145 91 63 53 72 45 53 70 38 43 55
2025/20261.054 127 47 139 61 83 49 154 152 143 97 2 0
Totale 11.585